CYDXCYduct Diagnostics Inc.

About CYduct Diagnostics Inc. (CYDX)

CYduct Diagnostics Inc. (CYDX) is a Medical Devices company headquartered in Westport, CT, United States whose shares trade over-the-counter on the Pink tier.

CYduct Diagnostics, Inc., headquartered in Westport, Connecticut, develops, produces, and markets medical products for the assessment, identification, diagnosis and ultimately treatment of early-stage breast disease. CYduct will provide personalized risk assessment tools and help identify precancerous and cancerous lesions within the mammary ducts. The CYduct technology platforms will be single-use, proprietary, high-margin, high-volume suite of breast care products which assess, screen, detect, monitor and treat identifiable changes that distinguish variations in breast health. CYduct is committed to providing both women and clinicians with noninvasive and minimally invasive technology that will continue to accelerate the intraductal evolution and improvement in the ability to: 1) assess breast health risk, 2) monitor breast health, 3) identify the need for increased personalized risk surveillance and 4) provide the tools to monitor, diagnose/treat breast disease through visual examination (Breast Endoscopy) within the ductal system of the breast.

Products and services

Products for use in the early assessment and detection of breast cancer.

CYDX key facts

Ticker symbol

CYDX

Market tier

Pink

Sector

Healthcare

Industry

Medical Devices

Headquarters

Westport, CT, United States

Country of incorporation

US

Year of incorporation

2005

Employees

6

Estimated market cap

$1.06M (as of Apr 16, 2025)

Shares outstanding

5,240,857

Reporting standard

Alternative Reporting Standard

Audit status

Unaudited

Fiscal year end

6/30

Latest filing

Quarterly Report (Dec 31, 2024)

CYduct Diagnostics Inc. leadership

• Dom Gatto — President, CEO
• Claus Madsen — CFO

Explore more: Medical Devices stocks · Healthcare sector · Pink stocks · OTC stocks starting with C